View in EDS HTML Full Text PDF Full Text

Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.

Saved in:
Bibliographic Details
Title: Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.
Authors: Huber H; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; German Center of Neurodegenerative Diseases (DZNE), Bonn, Germany., Arranz J; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Arslan B; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden., Leuzy A; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Banner Alzheimer's Institute, Phoenix, AZ, USA.; Banner Sun Health Research Institute, Sun City, AZ, USA., Kittel O; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden., di Molfetta G; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden., Benejam B; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain., Videla L; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Barroeta I; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Soriano LDH; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Maure-Blesa L; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Rodríguez-Baz Í; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Arriola Infante JE; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.; Department of Neurology, Torrecárdenas University Hospital, Almería, Spain., Illán-Gala I; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Bejanin A; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Montoliu-Gaya L; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden., Lleó A; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Carmona-Iragui M; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Alcolea D; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Blennow K; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, Neurodegenerative Disorder Research Center, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, China., Zetterberg H; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, InnoHK, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Fortea J; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Ashton NJ; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden. nicholas.ashton@gu.se.; Banner Alzheimer's Institute, Phoenix, AZ, USA. nicholas.ashton@gu.se.; Banner Sun Health Research Institute, Sun City, AZ, USA. nicholas.ashton@gu.se.
Source: Nature communications [Nat Commun] 2025 Nov 10; Vol. 16 (1), pp. 9900. Date of Electronic Publication: 2025 Nov 10.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41213934
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huber+H%22">Huber H</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; German Center of Neurodegenerative Diseases (DZNE), Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Arranz+J%22">Arranz J</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Arslan+B%22">Arslan B</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Leuzy+A%22">Leuzy A</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Banner Alzheimer's Institute, Phoenix, AZ, USA.; Banner Sun Health Research Institute, Sun City, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Kittel+O%22">Kittel O</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22di+Molfetta+G%22">di Molfetta G</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Benejam+B%22">Benejam B</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Videla+L%22">Videla L</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Barroeta+I%22">Barroeta I</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Soriano+LDH%22">Soriano LDH</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Maure-Blesa+L%22">Maure-Blesa L</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Baz+Í%22">Rodríguez-Baz Í</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Arriola+Infante+JE%22">Arriola Infante JE</searchLink>; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.; Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.<br /><searchLink fieldCode="AU" term="%22Illán-Gala+I%22">Illán-Gala I</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bejanin+A%22">Bejanin A</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Montoliu-Gaya+L%22">Montoliu-Gaya L</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Lleó+A%22">Lleó A</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Carmona-Iragui+M%22">Carmona-Iragui M</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alcolea+D%22">Alcolea D</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Blennow+K%22">Blennow K</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, Neurodegenerative Disorder Research Center, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, China.<br /><searchLink fieldCode="AU" term="%22Zetterberg+H%22">Zetterberg H</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, InnoHK, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Fortea+J%22">Fortea J</searchLink>; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ashton+NJ%22">Ashton NJ</searchLink>; Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden. nicholas.ashton@gu.se.; Banner Alzheimer's Institute, Phoenix, AZ, USA. nicholas.ashton@gu.se.; Banner Sun Health Research Institute, Sun City, AZ, USA. nicholas.ashton@gu.se.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Nov 10; Vol. 16 (1), pp. 9900. <i>Date of Electronic Publication: </i>2025 Nov 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41213934
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-65882-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 9900
    Titles:
      – TitleFull: Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huber H
      – PersonEntity:
          Name:
            NameFull: Arranz J
      – PersonEntity:
          Name:
            NameFull: Arslan B
      – PersonEntity:
          Name:
            NameFull: Leuzy A
      – PersonEntity:
          Name:
            NameFull: Kittel O
      – PersonEntity:
          Name:
            NameFull: di Molfetta G
      – PersonEntity:
          Name:
            NameFull: Benejam B
      – PersonEntity:
          Name:
            NameFull: Videla L
      – PersonEntity:
          Name:
            NameFull: Barroeta I
      – PersonEntity:
          Name:
            NameFull: Soriano LDH
      – PersonEntity:
          Name:
            NameFull: Maure-Blesa L
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Baz Í
      – PersonEntity:
          Name:
            NameFull: Arriola Infante JE
      – PersonEntity:
          Name:
            NameFull: Illán-Gala I
      – PersonEntity:
          Name:
            NameFull: Bejanin A
      – PersonEntity:
          Name:
            NameFull: Montoliu-Gaya L
      – PersonEntity:
          Name:
            NameFull: Lleó A
      – PersonEntity:
          Name:
            NameFull: Carmona-Iragui M
      – PersonEntity:
          Name:
            NameFull: Alcolea D
      – PersonEntity:
          Name:
            NameFull: Blennow K
      – PersonEntity:
          Name:
            NameFull: Zetterberg H
      – PersonEntity:
          Name:
            NameFull: Fortea J
      – PersonEntity:
          Name:
            NameFull: Ashton NJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 11
              Text: 2025 Nov 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1